Categories
Connect with us on LinkedIn
The New Standard in Participant-Centric Trials: What Castor’s 2025 Updates Reveal About the Future of Clinical Research
Explore how Castor’s 2025 updates reduce site burden and boost compliance through scalable, flexible DTP workflows.
Oncobiomix: Slashing Costs and Elevating Data Quality
Discover how Oncobiomix used an integrated platform for eConsent, EDC, and ePRO to save $100K and streamline data...
Product Spotlight: What’s New in 2025?
Discover how Castor's latest product updates in 2025 can improve your day-to-day operations, and the participant experience.
Do Patients Really Understand Clinical Trials?
Poor comprehension of informed consent disrupts trials. Here’s how to fix it—with data, tech, and actual patient understanding.
Why a Life Sciences Museum Matters—And What It Can Teach Us About the Future of Medicine
What a Museum of Medicine can teach us about trials, trust, and how the public sees (or doesn’t...
Castor Steps Up to Preserve Critical Research Amid NIH Funding Cuts
Castor has announced free access to its clinical trial technology platform for U.S. researchers impacted by recent NIH...
How Advanced Neuromodulation Researchers Cut Study Build Time by 63% Using Integrated Trial Technology
This detailed case study reveals the practical strategies and technology solutions that enabled researchers to automate participant screening,...
Participant View eCOA | ePRO
Reduce participant and site burden with a simple 2 step onboarding and user-friendly app. Secure questionnaires via email...
eCOA/ePRO factsheet
Download our ePRO/eCOA factsheet to view an overview of our services.
Strategies to Minimize Participant and Healthcare Provider Burden in Clinical Trials
This article examines strategies to reduce participant and provider burden in clinical trials while ensuring high-quality data collection....
What do we measure with PROs in head and neck cancer? Pain, QoL, adverse events and more
Patient-Reported Outcomes (PROs) are essential in head and neck cancer research, offering insights into symptoms, quality of life,...
2024: Castor Year in Review
As we close the year, the Castor team shares vital milestones the company has achieved to make patient-centric...
Unlocking FDA’s Vision for PRO Collection in RWE: Timing, Methods, and Insights
Discover FDA's guidance on collecting PROs for Real-World Evidence (RWE), focusing on timing, methods, and improving data quality.
FDA’s Vision on PRO/eCOA Collection for RWE: Timing and Methods Explained
Watch back as our panel of experts discuss how the FDA views the collection of patient-reported outcomes for...
Castor Launches “Castor for Impact Program” to Advance Health Equity in Clinical Research
Innovative Program Offers Discounted or Free Access to Clinical Trial Technology, Empowering Underserved Research Areas and Early-Stage Biotech...
DTx company leverages Castor’s Real-World Evidence platform in Registry study
How Castor’s eClinical system helped a DTx company to collect Real World Evidence for their behavioral disorder treatment
Castor Product Spotlight: What’s new in 2024?
In this on-demand webinar, we delve into the latest product updates on eCOA, data entry, reports, and dashboards....
eCOA: Afterthought or Essential Strategy? An Expert’s View on Choosing and Developing an eCOA Strategy
The Evolving Landscape of eCOA in Clinical Trials Clinical trials have long grappled with the complexities of data...
Connect with us on LinkedIn
